Although chronic kidney diseases are, I think, unrelated to OSA,
there is maybe a fear among investors that, as Novo Nordisk is
becoming bigger and more and more profitable, it might be able
to muscle its way through studies and clinical trials whistle
minimising or silencing the negative news about Ozempic side effects.
Although chronic kidney diseases are, I think, unrelated to OSA,...
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$35.15 |
Change
0.700(2.03%) |
Mkt cap ! $21.55B | |||
| Open | High | Low | Value | Volume |
| $35.07 | $35.20 | $34.95 | $30.98M | 882.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 105 | $35.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $35.20 | 8620 | 3 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| RMD (ASX) Chart |